CONMED CORPORATION Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CONMED CORPORATION shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2015 was -$1.97M.
- CONMED CORPORATION shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2014 was -$6.14M, a 140.40% decline from fiscal 2013.
- CONMED CORPORATION shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2013 was $15.20M, a 70.55% increase from fiscal 2012.
- CONMED CORPORATION shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2012 was $8.91M, a 84.59% increase from fiscal 2011.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2015-12-31 | -$1.97M 10-K · filed 2016-02-23 | |
| 2014-12-31 | -$6.14M 10-K · filed 2016-02-23 | |
| 2013-12-31 | $15.20M 10-K · filed 2016-02-23 | |
| 2012-12-31 | $8.91M 10-K · filed 2015-02-23 | |
| 2011-12-31 | $4.83M 10-K · filed 2014-02-24 | |
| 2010-12-31 | $1.72M 10-K · filed 2013-02-25 | |
| 2009-12-31 | $755.00K 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |